$3.90
0.256.99%
Last update: Nov 9, 4:00 PM
Quoin Pharmaceuticals Ltd
QNRXNASDAQ
Quoin Pharmaceuticals fell 55.0% from $8.68 to $3.91, behind the S&P 500's +10.5%. Its worst day was Dec 5 (−36.1%), and its low came Jun 23 at $3.25.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Target Loadings of 4% and 5% Rapamycin Achieved for Topical Lotion and Dermal Patch Delivery Technologies RespectivelyClinical Trial and Stability Batch Manufacture to Commence in Q4 2025Clinical Testing in a Number of
+32.6%, the year's best day · S&P 500 +0.2%
Story events cover the past 12 months · Times ET
Quoin Pharmaceuticals closed at its highest level of the year, 156.9% above where the year started.
+13.8% · S&P 500 +0.9%
Quoin Pharmaceuticals shares fell 36.1%, while the S&P 500 rose 0.2%.
−36.1%, the year's worst day · S&P 500 +0.2%
Quoin Pharmaceuticals shares rose 24.6%, while the S&P 500 fell 1.1%.
+24.6% · S&P 500 −1.1%
EPS of $-1.74 beat the $-4.98 estimate on $0.00 revenue.
−18.4% · S&P 500 −1.8%
EPS of $-1.77 beat the $-2.17 estimate on $0.00 revenue.
−0.9% · S&P 500 −0.3%
Quoin Pharmaceuticals closed at its lowest level of the year, 62.6% below where the year started.
−26.3% · S&P 500 −1.5%
EPS of $-1.90 missed the $-1.78 estimate on $0.00 revenue.
−15.9% · S&P 500 −0.2%
Quoin Pharmaceuticals shares rose 27.2%, while the S&P 500 fell 0.2%.
+27.2%, on 31M shares, the year's heaviest volume · S&P 500 −0.2%
EPS of $-0.97 beat the $-1.78 estimate on $0.00 revenue.
−4.8% · S&P 500 −4.4%
Where it ended: a close of $3.90 on Nov 9, 2026.
Nothing in the past 12 months.
All QNRX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for QNRX and SPY from Benzinga historical bars. Not investment advice.
